Works matching IS 10781552 AND DT 2016 AND VI 22
Results: 127
Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 3, p. 430, doi. 10.1177/1078155215594417
- By:
- Publication type:
- Article
Comparison of two different formulas for body surface area in adults at extremes of height and weight.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 690, doi. 10.1177/1078155215599669
- By:
- Publication type:
- Article
Abstracts.
- Published in:
- 2016
- Publication type:
- Abstract
Use of vemurafenib in a patient unable to swallow whole.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 733, doi. 10.1177/1078155215603231
- By:
- Publication type:
- Article
Abstracts from the Global Pharmacy and Health Care Services Research Summit (GPHSRS) 2016.
- Published in:
- 2016
- Publication type:
- Abstract
Low rate of cetuximab hypersensitivity reactions in Northeast Tennessee: An Appalachian effect?
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 784, doi. 10.1177/1078155215618771
- By:
- Publication type:
- Article
Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 777, doi. 10.1177/1078155215612541
- By:
- Publication type:
- Article
Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 806, doi. 10.1177/1078155215611048
- By:
- Publication type:
- Article
Successful use of high-dose cytarabine in a patient with acute myeloid leukemia and severe hepatic dysfunction.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 811, doi. 10.1177/1078155215610916
- By:
- Publication type:
- Article
Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in Belgium.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 766, doi. 10.1177/1078155215610915
- By:
- Publication type:
- Article
Routine proteinuria monitoring for bevacizumab in patients with gynecologic malignancies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 771, doi. 10.1177/1078155215609987
- By:
- Publication type:
- Article
Effect of ceftriaxone and cefepime on high-dose methotrexate clearance.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 801, doi. 10.1177/1078155215608524
- By:
- Publication type:
- Article
Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 741, doi. 10.1177/1078155215608523
- By:
- Publication type:
- Article
Cytarabine syndrome despite corticosteroid premedication in an adult undergoing induction treatment for acute myelogenous leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 795, doi. 10.1177/1078155215607090
- By:
- Publication type:
- Article
Retrospective analysis of pharmacist interventions in an ambulatory palliative care practice.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 757, doi. 10.1177/1078155215607089
- By:
- Publication type:
- Article
Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 749, doi. 10.1177/1078155215607088
- By:
- Publication type:
- Article
Activity of single-agent decitabine in atypical chronic myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 790, doi. 10.1177/1078155215605662
- By:
- Publication type:
- Article
Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 702, doi. 10.1177/1078155215625459
- By:
- Publication type:
- Article
Stability of lenalidomide suspension after preparation by a simple suspension method for enteral tube administration.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 4, p. 579, doi. 10.1177/1078155215593623
- By:
- Publication type:
- Article
Abstracts.
- Published in:
- 2016
- Publication type:
- Abstract
Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 666, doi. 10.1177/1078155215603230
- By:
- Publication type:
- Article
Comorbidities among patients with cancer who do and do not develop febrile neutropenia during the first chemotherapy cycle.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 679, doi. 10.1177/1078155215603229
- By:
- Publication type:
- Article
Stability of four standardized preparations of methotrexate, cytarabine, and hydrocortisone for intrathecal use.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 659, doi. 10.1177/1078155215600905
- By:
- Publication type:
- Article
Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 2, p. 212, doi. 10.1177/1078155214556523
- By:
- Publication type:
- Article
Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 696, doi. 10.1177/1078155215597558
- By:
- Publication type:
- Article
Tyrosine kinase inhibitor-associated syndrome of inappropriate secretion of anti-diuretic hormone.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 729, doi. 10.1177/1078155215592023
- By:
- Publication type:
- Article
Systemic capillary leak syndrome in a patient receiving adjuvant oxaliplatin for locally advanced colon cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 725, doi. 10.1177/1078155215591388
- By:
- Publication type:
- Article
Fatal pulmonary toxicity due to carfilzomib (Kyprolis™).
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 720, doi. 10.1177/1078155215588630
- By:
- Publication type:
- Article
A first case report of diffuse acneiform eruption caused by capecitabine in a patient with small-cell neuroendocrine lung carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 717, doi. 10.1177/1078155215587542
- By:
- Publication type:
- Article
A review of blinatumomab, a novel immunotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 4, p. 639, doi. 10.1177/1078155215618770
- By:
- Publication type:
- Article
A review in the treatment of oncologic emergencies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 4, p. 625, doi. 10.1177/1078155215605661
- By:
- Publication type:
- Article
Biosimilars: Hope and concern.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 4, p. 618, doi. 10.1177/1078155215603232
- By:
- Publication type:
- Article
Initiation and preliminary evaluation of an oncology pharmacy training course for staff pharmacists.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 4, p. 611, doi. 10.1177/1078155215599834
- By:
- Publication type:
- Article
Tolerability of Vidaza (azacitidine) subcutaneous administration using a maximum volume of 3 ml per injection.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 4, p. 605, doi. 10.1177/1078155215598854
- By:
- Publication type:
- Article
Loading, release and stability of epirubicin-loaded drug-eluting beads.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 4, p. 591, doi. 10.1177/1078155215594416
- By:
- Publication type:
- Article
Is it equivalent? Evaluation of the clinical activity of single agent Lipodox® compared to single agent Doxil® in ovarian cancer treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 4, p. 599, doi. 10.1177/1078155215594415
- By:
- Publication type:
- Article
Severe and irreversible myelopathy after concurrent systemic and intrathecal nucleoside analogue treatment for refractory diffuse large B-cell lymphoma: A case report and review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 3, p. 523, doi. 10.1177/1078155214562268
- By:
- Publication type:
- Article
Outcomes of hospitalized neutropenic oncology patients with Pseudomonas aeruginosa bloodstream infections: focus on oral fluoroquinolone conversion.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 4, p. 584, doi. 10.1177/1078155215591389
- By:
- Publication type:
- Article
Two cases of breast carcinoma during pregnancy and review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 4, p. 652, doi. 10.1177/1078155215587540
- By:
- Publication type:
- Article
Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 4, p. 646, doi. 10.1177/1078155215586235
- By:
- Publication type:
- Article
Re: Dasanu et al. Muehrcke’s lines (Leukonychiastriata) due to transretinoic acid therapy for acute promyelocytic leukemia. J Oncol Pharm Pract, published 2013, 19(4): 377–379. Beau’s lines versus Muehrcke’s lines:One is never too old to learn.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Re: Dasanu et al. Muehrcke's lines (Leukonychiastriata) due to transretinoic acid therapy for acute promyelocytic leukemia. Case report showed Beau’s lines or onychomadesis, not Muehrcke’s lines.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Incompatibility of busulfan with 1 ml Luer-Lock syringes.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Methemoglobinemia secondary to rasburicase in cancer: Non drug-related oxidative stress.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Prophylaxis and treatment recommendations for sinusoidal obstruction syndrome in adult and pediatric patients undergoing hematopoietic stem cell transplant: a review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 3, p. 496, doi. 10.1177/1078155215591387
- By:
- Publication type:
- Article
Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 3, p. 448, doi. 10.1177/1078155215591386
- By:
- Publication type:
- Article
Assessment of mental health literacy in patients with breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 3, p. 437, doi. 10.1177/1078155215587541
- By:
- Publication type:
- Article
Evidence-based practice in times of drug shortage.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 3, p. 566, doi. 10.1177/1078155215589980
- By:
- Publication type:
- Article
Once daily versus twice daily enoxaparin for acute pulmonary embolism in cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 2, p. 265, doi. 10.1177/1078155215583374
- By:
- Publication type:
- Article
The role of screening and monitoring for bleomycin pulmonary toxicity.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 2, p. 308, doi. 10.1177/1078155215574294
- By:
- Publication type:
- Article